Search research articles
Contact Us
Filters
Showing results (31-40 of 34) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 34 results.
Journal of Biomedical Materials Research. Part A
|
October 10, 2025
In Vitro Assessment and Preliminary In Vivo Characterization of Innovative Hybrid Materials for Biomedical Applications
Martina Todesco, Roberto Luisetto, Martina Casarin, et al.
International Journal of Environmental Research and Public Health
|
September 30, 2020
Upper and Lower Respiratory Signs and Symptoms in Workers Occupationally Exposed to Flour Dust
Maria Angiola Crivellaro, Giancarlo Ottaviano, Pietro Maculan, et al.
Cell Transplantation
|
September 30, 2008
Cochlear repair by transplantation of human cord blood CD133+ cells to nod-scid mice made deaf with kanamycin and noise
Roberto P Revoltella, Sandra Papini, Alfredo Rosellini, et al.
Cell Death Discovery
|
January 19, 2026
Targeting metabolic vulnerabilities: REV-ERB agonist SR9009 potentiates sorafenib efficacy in liver cancer
Silvia Sabbioni, Paola Guerriero, Ram C Shankaraiah, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 34) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 34 results.
Journal of Biomedical Materials Research. Part A
|
October 10, 2025
In Vitro Assessment and Preliminary In Vivo Characterization of Innovative Hybrid Materials for Biomedical Applications
Martina Todesco, Roberto Luisetto, Martina Casarin, et al.
International Journal of Environmental Research and Public Health
|
September 30, 2020
Upper and Lower Respiratory Signs and Symptoms in Workers Occupationally Exposed to Flour Dust
Maria Angiola Crivellaro, Giancarlo Ottaviano, Pietro Maculan, et al.
Cell Transplantation
|
September 30, 2008
Cochlear repair by transplantation of human cord blood CD133+ cells to nod-scid mice made deaf with kanamycin and noise
Roberto P Revoltella, Sandra Papini, Alfredo Rosellini, et al.
Cell Death Discovery
|
January 19, 2026
Targeting metabolic vulnerabilities: REV-ERB agonist SR9009 potentiates sorafenib efficacy in liver cancer
Silvia Sabbioni, Paola Guerriero, Ram C Shankaraiah, et al.
Page
of 4